Stocktoria
Akari Therapeutics Plc AKTX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-01-31
Akari Therapeutics Plc insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Farag Kameel D. | Interim CFO | 2026-06-24 | Grant | 1,248 | $10.02 |
| Farag Kameel D. | Interim CFO | 2026-06-24 | Grant | 1,395 | $9.32 |
| Farag Kameel D. | Interim CFO | 2026-06-24 | Grant | 1,570 | $8.28 |
| Farag Kameel D. | Interim CFO | 2026-06-24 | Grant | 2,539 | $5.12 |
| Farag Kameel D. | Interim CFO | 2026-06-24 | Grant | 3,725 | $3.49 |
| Farag Kameel D. | Interim CFO | 2026-06-24 | Grant | 7,353 | $3.74 |
| Farag Kameel D. | Interim CFO | 2026-06-24 | Grant | 1,000 | $13.00 |
Source: SEC EDGAR filings · CIK 0001541157 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.